Bradykinin potentiation by ACE inhibitors: a matter of metabolism

Por Tom, Beril, Dendorfer, Andreas, Vries, René de, Saxena, Pramod R, Jan Danser, A H
Publicado em 2002

Long-Term Use of Aldosterone-Receptor Antagonists in Uncontrolled Hypertension: A Retrospective Analysis

Por Jansen, Pieter M., Verdonk, Koen, Imholz, Ben P., Jan Danser, A. H., van den Meiracker, Anton H.
Publicado em 2011

Recent advances in hypertension and cardiovascular toxicities with vascular endothelial growth factor (VEGF) inhibition

Por Touyz, Rhian M, Lang, Ninian N, Herrmann, Joerg, van den Meiracker, Anton H, Jan Danser, A. H.
Publicado no Hypertension (2017)

AT(2) receptor-mediated vasodilation in the mouse heart depends on AT(1A) receptor activation

Por van Esch, Joep H M, Schuijt, Martin P, Sayed, Jilani, Choudhry, Yawar, Walther, Thomas, Jan Danser, A H
Publicado em 2006

Phosphodiesterase-5 activity exerts a coronary vasoconstrictor influence in awake swine that is mediated in part via an increase in endothelin production

Por Zhou, Zhichao, de Beer, Vincent J., Bender, Shawn B., Jan Danser, A. H., Merkus, Daphne, Laughlin, M. Harold, Duncker, Dirk J.
Publicado em 2014

Altered purinergic signaling in uridine adenosine tetraphosphate-induced coronary relaxation in swine with metabolic derangement

Por Zhou, Zhichao, Sorop, Oana, de Beer, Vincent J., Heinonen, Ilkka, Cheng, Caroline, Jan Danser, A. H., Duncker, Dirk J., Merkus, Daphne
Publicado no Purinergic Signal (2017)

Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.

Por Wagner, J, Jan Danser, A H, Derkx, F H, de Jong, T V, Paul, M, Mullins, J J, Schalekamp, M A, Ganten, D
Publicado em 1996